Tegsedi (inotersen)

pCPA File Number: 21156
Negotiation Status:
Concluded with an LOI
Indication(s):
hereditary transthyretin-mediated amyloidosis
Sponsor/Manufacturer:
Akcea Therapeutics Inc.
CADTH Project Number:
SR0603-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: